Susanne Kirchner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Susanne Kirchner has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Zbigniew L. Pianowski
Institute of Organic Chemistry, Karlsruhe Institute of Technology KIT, 76131, Karlsruhe, Germany.
3 shared publications Angelika Seliwjorstow
Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany
1 shared publication- Angelika Seliwjorstow
Institute of Organic Chemistry IOC, Karlsruhe Institute of Technology, Karlsruhe, Germany
1 shared publication - Anna‐Lena Leistner
Institute of Organic Chemistry Karlsruhe Institute of Technology KIT Fritz-Haber-Weg 6 76131 Karlsruhe Germany
1 shared publication - Johannes Karcher
Institute of Organic Chemistry, Karlsruhe Institute of Technology, Karlsruhe, Germany
1 shared publication - Marius Bach
Institute of Organic Chemistry Karlsruhe Institute of Technology (KIT) Kaiserstrasse 12 76131 Karlsruhe Germany
1 shared publication
Latest Publications
- Open Access
- 15 March 2024
- Published by Wiley in Macromolecular Materials and Engineering
- Vol. 309 (5)
Visible Light‐Triggered Supramolecular Hydrogel Based on Cyclic Dipeptides Stabilized with Coulomb Interactions
Amphiphilic cyclic dipeptides are efficient supramolecular hydrogelators. They can be combined with molecular photoswitches to produce light‐responsive soft materials, which can be applied in controlled drug delivery. Here it is reported that an arginine‐containing cyclic dipeptide decorated with ortho‐fluorinated azobenzene forms hydrogels under physiological conditions that can be reversibly liquefied upon exposure to visible light frequencies (green and violet, respectively). The addition of sodium alginate results in composite supramolecular hydrogels with increased gelating capacity supported with Coulombic interactions, which also reversibly dissipate upon irradiation.
- 15 March 2024
- Published by Wiley in Macromolecular Materials and Engineering
- Vol. 309 (5)
Open AccessVisible Light‐Triggered Supramolecular Hydrogel Based on Cyclic Dipeptides Stabilized with Coulomb Interactions
Amphiphilic cyclic dipeptides are efficient supramolecular hydrogelators. They can be combined with molecular photoswitches to produce light‐responsive soft materials, which can be applied in controlled drug delivery. Here it is reported that an arginine‐containing cyclic dipeptide decorated with ortho‐fluorinated azobenzene forms hydrogels under physiological conditions that can be reversibly liquefied upon exposure to visible light frequencies (green and violet, respectively). The addition of sodium alginate results in composite supramolecular hydrogels with increased gelating capacity supported with Coulombic interactions, which also reversibly dissipate upon irradiation.
- Open Access
- 14 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Hemipiperazines as peptide-derived molecular photoswitches with low-nanomolar cytotoxicity
Molecular photoswitches transform light energy into reversible structural changes. Their combination with known pharmacophores often allows for photomodulation of the biological activity. The effort to apply such compounds in photopharmacology as light-activated pro-drugs is, however, hampered by serious activity reduction upon pharmacophore modifications, or limited biostability. Here we report that a potent antimitotic agent plinabulin and its derivatives demonstrate up to 56-fold reversible activity photomodulation. Alternatively, irreversible photoactivation with cyan light can enhance the cytotoxicity up to three orders of magnitude—all without compromising the original activity level, as the original pharmacophore structure is unchanged. This occurs due to the presence of a peptide-derived photoswitchable motif hemipiperazine inside the plinabulin scaffold. Furthermore, we systematically describe photochromism of these thermally stable and biocompatible hemipiperazines, as well as a photoswitchable fluorophore derived from plinabulin. The latter may further expand the applicability of hemipiperazine photochromism towards super-resolution microscopy.
- 14 October 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Open AccessHemipiperazines as peptide-derived molecular photoswitches with low-nanomolar cytotoxicity
Molecular photoswitches transform light energy into reversible structural changes. Their combination with known pharmacophores often allows for photomodulation of the biological activity. The effort to apply such compounds in photopharmacology as light-activated pro-drugs is, however, hampered by serious activity reduction upon pharmacophore modifications, or limited biostability. Here we report that a potent antimitotic agent plinabulin and its derivatives demonstrate up to 56-fold reversible activity photomodulation. Alternatively, irreversible photoactivation with cyan light can enhance the cytotoxicity up to three orders of magnitude—all without compromising the original activity level, as the original pharmacophore structure is unchanged. This occurs due to the presence of a peptide-derived photoswitchable motif hemipiperazine inside the plinabulin scaffold. Furthermore, we systematically describe photochromism of these thermally stable and biocompatible hemipiperazines, as well as a photoswitchable fluorophore derived from plinabulin. The latter may further expand the applicability of hemipiperazine photochromism towards super-resolution microscopy.
- Open Access
- 18 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (10) , 5657
Photopharmacology of Antimitotic Agents
Antimitotic agents such as the clinically approved vinca alkaloids, taxanes and epothilone can arrest cell growth during interphase and are therefore among the most important drugs available for treating cancer. These agents suppress microtubule dynamics and thus interfere with intracellular transport, inhibit cell proliferation and promote cell death. Because these drugs target biological processes that are essential to all cells, they face an additional challenge when compared to most other drug classes. General toxicity can limit the applicable dose and therefore reduce therapeutic benefits. Photopharmacology aims to avoid these side-effects by introducing compounds that can be applied globally to cells in their inactive form, then be selectively induced to bioactivity in targeted cells or tissue during a defined time window. This review discusses photoswitchable analogues of antimitotic agents that have been developed by combining different photoswitchable motifs with microtubule-stabilizing or microtubule-destabilizing agents.
- 18 May 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (10) , 5657
Open AccessPhotopharmacology of Antimitotic Agents
Antimitotic agents such as the clinically approved vinca alkaloids, taxanes and epothilone can arrest cell growth during interphase and are therefore among the most important drugs available for treating cancer. These agents suppress microtubule dynamics and thus interfere with intracellular transport, inhibit cell proliferation and promote cell death. Because these drugs target biological processes that are essential to all cells, they face an additional challenge when compared to most other drug classes. General toxicity can limit the applicable dose and therefore reduce therapeutic benefits. Photopharmacology aims to avoid these side-effects by introducing compounds that can be applied globally to cells in their inactive form, then be selectively induced to bioactivity in targeted cells or tissue during a defined time window. This review discusses photoswitchable analogues of antimitotic agents that have been developed by combining different photoswitchable motifs with microtubule-stabilizing or microtubule-destabilizing agents.